Remote monitoring and education for postpartum blood pressure management

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the feasibility of a structured postpartum remote blood pressure monitoring program combined with patient education and regular text reminders. Participants will receive an educational video on hypertension during pregnancy and daily text messages for six weeks postpartum. The intervention includes individualized follow-up for medication adjustments to achieve lower blood pressure targets. The study seeks to determine if this approach can effectively reduce postpartum hypertension and related adverse outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Age of at least 18 years.
2. Postpartum status.
3. Experience new-onset hypertension during pregnancy.
4. Enrollment in Connected MOM.
5. Ability to provide informed consent.
6. Establish medical care within the Ochsner System to facilitate data collection.

Exclusion Criteria:

1. History of preeclampsia or gestational hypertension during previous pregnancy
2. History of chronic hypertension
3. History of coronary artery disease (myocardial infarction, coronary stent placement, coronary artery bypass grafting, spontaneous coronary artery dissection)
4. History of ischemic CVA
5. History of Congestive heart failure
6. Renal dysfunction
7. Liver dysfunction
8. Left ventricular dysfunction
9. Congenital heart disease
10. Still birth at delivery

Where it's running

• Ochsner Baptist
  New Orleans, Louisiana, United States Recruiting

Study contacts

• Study coordinator: Salima Qamruddin, MD
• Email: salima.qamruddin@ochsner.org
• Phone: +1 (504) 842-4135

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Pre-eclampsia risk in pregnancies after oocyte donation

  We will follow pregnant women who used donated eggs and women who used their own eggs to see if pregnancies after oocyte donation lead to a higher risk of pre-eclampsia.

  Recruiting at 6 sites Copenhagen University Hospital, Hvidovre · Copenhagen and 5 other locations · NCT07263490

• Use of metformin to prolong pregnancy in preterm preeclampsia in the Netherlands

  In pregnant people with preterm preeclampsia, this study tests whether metformin can help them stay pregnant longer compared with placebo.

  Recruiting Phase 3 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam · NCT06452498

• Using dapagliflozin to reduce cardiovascular risk after hypertensive pregnancies

  This study is testing if the medication dapagliflozin can help reduce heart risks for women who had high blood pressure during pregnancy after they give birth.

  Recruiting Phase 4 University of Michigan · Ann Arbor, Michigan · NCT06785116

• Using low-dose aspirin after preeclampsia to improve recovery

  This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.

  Recruiting Phase 4 University of Pittsburgh · Pittsburgh, Pennsylvania · NCT06281665

• Understanding postpartum pulmonary artery pressure in women with preeclampsia and antiphospholipid syndrome

  This study looks at the heart health of women who had high blood pressure during pregnancy and also have a specific blood condition, to see how these issues affect them after childbirth.

  Recruiting Insel Gruppe AG, University Hospital Bern · Bern · NCT05679206

• Predicting progression from gestational hypertension to preeclampsia in pregnant women

  This study is trying to find out if certain blood vessel markers can help predict if pregnant women with gestational hypertension will develop preeclampsia.

  Recruiting at 3 sites Assistance Publique - Hôpitaux de Paris · Bobigny, Seine Saint Denis and 2 other locations · NCT04520048

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.